Researchers Develop Blood Test To Measure Glycan Generated By Pancreatic Cancers That Generally Do Not Respond To Chemotherapy

Healio (11/20, Byrne) reported researchers “developed and evaluated a blood test that measures concentrations of a glycan called sTRA,” which “is generated by pancreatic cancers that generally do not respond to chemotherapy.” The findings were published i...